This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Mar;11(2):375.

doi: 10.1097/UPJ.0000000000000517.01. Epub 2024 Feb 20.

Editorial Comment

Affiliations

PMID: 38377162
DOI: 10.1097/UPJ.0000000000000517.01

Editorial

Editorial Comment

Armine Smith. Urol Pract. 2024 Mar.

. 2024 Mar;11(2):375.

doi: 10.1097/UPJ.0000000000000517.01. Epub 2024 Feb 20.

Author

Affiliation

¹ Brady Urologic Institute, Johns Hopkins University, Baltimore, Maryland.

PMID: 38377162
DOI: 10.1097/UPJ.0000000000000517.01

No abstract available

PubMed Disclaimer

Comment on

Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer.
Chamie K, Chang SS, Kramolowsky EV, Gonzalgo ML, Huang M, Bhar P, Spilman P, Sender L, Reddy SK, Soon-Shiong P. Chamie K, et al. Urol Pract. 2024 Mar;11(2):367-375. doi: 10.1097/UPJ.0000000000000517. Epub 2024 Jan 16. Urol Pract. 2024. PMID: 38226931 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources